Kais mnafgui
Pharma & medical devices
APCRA Limited
Hong Kong
Biography
His focus is on controlled drug delivery products in general with a strong emphasis on transdermal drug delivery systems. In a consulting role, he served as Interim Vice President of R&D at Micell Technologies, a company developing a sirolimus eluting, bioabsorbable polymer coated coronary artery stent. He has served as an expert witness in several patent litigation cases involving transdermal technology.
Research Interest
Pharmaceutical sciences
